Drugs / Emthexate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04532736 | Sep 2017 → Mar 2019 | nasal cavity polyp | Dokuz Eylul University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Emthexate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04532736 ↗ |
| Route | Oral | “10 mg Emthexate, PO, once a week during 8 weeks” NCT04532736 ↗ |